STOCK TITAN

Sensus Healthcare Inc - SRTS STOCK NEWS

Welcome to our dedicated news page for Sensus Healthcare (Ticker: SRTS), a resource for investors and traders seeking the latest updates and insights on Sensus Healthcare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sensus Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sensus Healthcare's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.7%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.86%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.12%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.73%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.14%
Tags
conferences earnings
Sensus Healthcare Inc

Nasdaq:SRTS

SRTS Rankings

SRTS Stock Data

55.41M
13.07M
21.39%
17.05%
0.2%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Boca Raton

About SRTS

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.